NSC |
Compound |
Enrichment |
Correlation |
NSC 693142 |
Null |
0.0141370771633662 |
-0.057891917 |
NSC 693146 |
Null |
0.0141370771633662 |
-0.033491186 |
NSC 700583 |
[1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- |
0.0141370771633662 |
0.15777134 |
NSC 710554 |
Null |
0.0141370771633662 |
0.27329494 |
NSC 730632 |
{6-(3-Amino-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylen edioxy-5,11-dioxo-11H-indeno[1,2-c]-isoquinoline}-{5',6'-Dih ydro-6'-(3'-amino-1'-propyl)-5',11'-dioxo-11'H-indeno[1,2-c] -isoquinoline}pr |
0.0141370771633662 |
0.087255544 |
NSC 758230 |
Floxuridine (USAN) |
0.0141370771633662 |
-0.05405911 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0147237897640499 |
0.28155374 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0147237897640499 |
0.32440157 |
NSC 617394 |
Null |
0.0147237897640499 |
0.3636325 |
NSC 624657 |
ANTINEOPLASTIC-624657 |
0.0147237897640499 |
0.15173606 |